Impact of guselkumab on fatigue and mediation analysis of independent treatment effect of guselkumab on fatigue in patients with active psoriatic arthritis: Results from DISCOVER-1&2

被引：0
|
作者：
Rahman, Proton [1 ]
Helliwell, Philip S. [2 ]
Deodhar, Atul [3 ]
Kollmeier, Alexa P. [4 ]
Hsia, Elizabeth [4 ,5 ]
Zhou, Bei [4 ]
Lin, Xiwu [4 ]
Han, Chenglong [4 ]
Yang, Ya-Wen [4 ]
Mease, Philip J. [6 ]
机构：
[1] Mem Univ Newfoundland, St John, NF, Canada
[2] Univ Leeds, Leeds, W Yorkshire, England
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Janssen Res & Dev LLC, Raritan, NJ USA
[5] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA
[6] Univ Washington, Swedish Med Ctr, Prov St Joseph Hlth, Seattle, WA 98195 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
27594
引用
收藏
页码：AB153 / AB153
页数：1
相关论文
共 50 条
  • [21] Safety of guselkumab in patients with psoriatic arthritis through 1 year: Pooled findings from DISCOVER-1 and DISCOVER-2 phase 3 trials
    Ritchlin, Christopher T.
    Rahman, Proton
    Helliwell, Philip S.
    Boehncke, Wolf-Henning
    McInnes, Iain
    Gottlieb, Alice B.
    Kollmeier, Alexa P.
    Shawi, May
    Zhou, Bei
    Mease, Philip J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB151 - AB151
  • [22] Efficacy of guselkumab using composite endpoints in patients with active psoriatic arthritis: Domain-specific efficacy from DISCOVER-1 and DISCOVER-2 phase 3 trials
    Coates, Laura C.
    Ritchlin, Christopher T.
    Gossec, Laure
    Helliwell, Philip S.
    Rahman, Proton
    Kollmeier, Alexa P.
    Karyekar, Chetan
    Sheng, Shihong
    Agarwal, Prasheen
    Mease, Philip J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB127 - AB127
  • [23] Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
    Georg Schett
    Matthew J. Loza
    Arumugam Palanichamy
    Oliver FitzGerald
    Christopher Ritchlin
    Anne-Christine Bay-Jensen
    Signe Holm Nielsen
    Sheng Gao
    Elizabeth C. Hsia
    Alexa P. Kollmeier
    Xie L. Xu
    Frédéric Baribaud
    Kristen Sweet
    Rheumatology and Therapy, 2022, 9 : 1017 - 1030
  • [24] Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
    Schett, Georg
    Loza, Matthew J.
    Palanichamy, Arumugam
    FitzGerald, Oliver
    Ritchlin, Christopher
    Bay-Jensen, Anne-Christine
    Nielsen, Signe Holm
    Gao, Sheng
    Hsia, Elizabeth C.
    Kollmeier, Alexa P.
    Xu, Xie L.
    Baribaud, Frederic
    Sweet, Kristen
    RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 1017 - 1030
  • [25] Guselkumab Provides Sustained Improvements in Work Productivity and Daily Activity in Patients with Active Psoriatic Arthritis Through 2 Years of DISCOVER-2
    Curtis, Jeffrey
    McInne, Iain B.
    Rahman, Proton
    Gladman, Dafna
    Yang, Feifei
    Peterson, Steve
    Kollmeier, Alexa
    Shiff, Natalie
    Han, Chenglong
    Shawi, May
    Tillett, William
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1014 - 1016
  • [26] Relationships Between Fatigue and Hemoglobin/C-Reactive Protein Levels and Associations Between Fatigue and Clinical Response in Patients with Active Psoriatic Arthritis: Results from Two Randomized Controlled Trials of Guselkumab (TREMFYA®)
    Rahman, Proton
    Mease, Philip
    Deodhar, Atul
    Gossec, Laure
    Kavanaugh, Arthur
    Chakravarty, Soumya
    Kollmeier, Alexa
    Liu, Yan
    Lin, Xiwu
    Shawi, May
    Han, Chenglong
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3768 - 3770
  • [27] Guselkumab in Biologic-Naïve Patients with Active Psoriatic Arthritis in Russia: A Post Hoc Analysis of the DISCOVER-1 and-2 Randomized Clinical Trials
    Mease, Philip
    Korotaeva, Tatiana
    Shesternya, Pavel
    Kokhan, Muza
    Rukavitsyn, Anton
    Vasilchenkov, Dmitry
    Sharaf, Mohamed
    Lavie, Frederic
    Deodhar, Atul
    RHEUMATOLOGY AND THERAPY, 2024, 11 (06) : 1551 - 1567
  • [28] Relationships Between Fatigue and Hemoglobin/C-Reactive Protein Levels and Associations Between Fatigue and Clinical Response in Patients With Active Psoriatic Arthritis: Results From Two Randomized Controlled Trials of Guselkumab.
    Rahman, Proton
    Mease, Philip
    Deodhar, Atul
    Gossec, Laure
    Kavanaugh, Arthur
    Chakravarty, Soumya
    Kollmeier, Alexa
    Liu, Yang
    Lin, Xiwu
    Shawi, May
    Han, Chenglong
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 788 - 788
  • [29] GUSELKUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND DAILY ACTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 2 YEARS OF DISCOVER-2
    Curtis, J.
    Mcinnes, I.
    Rahman, P.
    Gladman, D. D.
    Yang, F.
    Peterson, S.
    Kollmeier, A.
    Shiff, N.
    Han, C.
    Shawi, M.
    Tillett, W.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1568 - 1569
  • [30] Effects of guselkumab on articular components of American College of Rheumatology score and skin responses in patients with active psoriatic arthritis: Results from the phase 3 DISCOVER-2 study
    Gottlieb, Alice B.
    Mease, Philip J.
    Merola, Joseph F.
    Kollmeier, Alexa P.
    Hsia, Elizabeth C.
    Xu, Xie L.
    Agarwal, Prasheen
    van der heijde, Desiree
    McInnes, Iain B.
    Boehncke, Wolf-Henning
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB145 - AB145
12345